The impact of circulating tumor cells (CTCs) detection in metastatic breast cancer (MBC): Implications of “indolent” stage IV disease (Stage IVindolent).

Authors

null

Andrew A. Davis

Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL

Andrew A. Davis , Jean-Yves Pierga , Luc Yves Dirix , Stefan Michiels , Alfred Rademaker , James M. Reuben , Tanja N. Fehm , Elisabetta Munzone , Mario Giuliano , Jose Vidal-Martinez , Dimitrios Mavroudis , Salvatore Grisanti , Daniele Giulio Generali , Jose Angel Garcia-Saenz , Justin Stebbing , Sarah-Jane Dawson , Paola Gazzaniga , François-Clément Bidard , Massimo Cristofanilli

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Breast Cancer—Metastatic

Track

Breast Cancer

Sub Track

Other Breast Cancer Subtypes

Citation

J Clin Oncol 36, 2018 (suppl; abstr 1019)

DOI

10.1200/JCO.2018.36.15_suppl.1019

Abstract #

1019

Poster Bd #

100

Abstract Disclosures

Similar Posters

First Author: Eleonora Nicolò

Poster

2020 ASCO Virtual Scientific Program

Surgery at primary and metastatic sites for stage IV breast cancer (BC): A National Cancer Database (NCDB) analysis.

Surgery at primary and metastatic sites for stage IV breast cancer (BC): A National Cancer Database (NCDB) analysis.

First Author: Nadeem Bilani

First Author: Julieta Leone